INTRODUCTION
Very small quantities of fetal blood enter the maternal circulation in essentially all pregnancies, 1,2 but the incidence of fetomaternal hemorrhage that is severe enough to cause fetal/neonatal anemia is not known. Using Kleihauer-Betke testing, Sebring et al., 3 Pollack et al. 4 and Rubod et al. 5 reported that fetomaternal hemorrhage X30 ml occurs once per 330 births. De Almeida and Bowman 6 reported that hemorrhages exceeding 150 ml of fetal blood occur once per 5000 births.
Fetomaternal hemorrhage is important to obstetrical practice as a cause of fetal death and stillbirth. 2, 7 It is also important to pediatricians and neonatologists, because such hemorrhage can be the source of neonatal hypovolemic shock, anemia, hydrops and respiratory distress. Best practice models for caring for these neonates should be based on data and evidence. However, most of the pertinent literature is in the form of single case reports and small case series, [8] [9] [10] [11] [12] [13] [14] owing to the relative rarity of the condition. We reasoned that information relevant to neonatal care might be obtained by identifying all recognized liveborn neonates with anemia and laboratory evidence of fetomaternal hemorrhage in the Intermountain Healthcare multihospital system.
METHODS
This was a retrospective analysis of clinical and laboratory data existing in Intermountain Healthcare data repositories. The Intermountain Healthcare Institutional Review Board approved the study as a deidentified data-only investigation not requiring written consent.
The experimental approach was to cohort the records of all live births cared for in any Intermountain Healthcare hospital with a date of birth between 1 January 2005 and 31 December 2011, and then to use two criteria to identify the study group from this cohort; (1) an initial hematocrit (Hct) on the day of birth of o30% or hemoglobin (Hgb) o10 g dl , and (2) laboratory evidence of fetomaternal hemorrhage obtained after delivery. The latter consisted of a positive Kleihauer-Betke stain of maternal blood or flow cytometric quantification of fetal blood in the maternal blood. Acid elution techniques such as Kleihauer-Betke stain testing have been shown to have a 96% sensitivity of detecting a 410-ml fetal maternal hemorrhage. 15 The electronic data sources were ICD9, Case Mix (the billing, coding and financial data mart used by Intermountain Healthcare) and EVOX (the extended Vermont-Oxford database).
Gestational age was determined by obstetrical assignment unless this was changed by the neonatologist on the basis of gestational age assessment (physical examination and neurological/neurodevelopmental findings). The Vermont/Oxford definitions 16 were used for severe intraventricular hemorrhage (IVH grade X3), periventricular leukomalacia and bronchopulmonary dysplasia.
The program used for data collection was a modified subsystem of 'clinical workstation'. Clinical workstation is a web-based electronic medical record application that stores demographic and clinical information, such as history, physical examination results, laboratory data, radiographic findings, problem lists and discharge summaries. The 3M Company (Minneapolis, MN, USA) approved the structure and definitions of all data points for use within the program.
RESULTS
Of the 219 853 live births in 20 hospitals during this period, 24 were identified as having anemia at birth (Hct o30% or Hgb o10 g dl À 1 ) with laboratory evidence of fetomaternal hemorrhage. Thus, the entity was recognized in 1 per 9160 live births. The annual number of cases recognized in our health system did not change appreciably over this period (three to five cases per year).
All 24 cases had a positive Kleihauer-Betke stain of mother's blood; 4 also had cytometric quantification of the volume of fetal blood in the maternal circulation. Laboratory reports in 10 read 'positive for fetal maternal hemorrhage' with no estimate of the percentage of fetal erythrocytes in the mother's blood. The 14 others were reported as 'positive for fetal maternal hemorrhage' and listed a percentage of fetal cells ranging from 0.9 and 6.2%. Flow cytometric estimates of the volume of fetal blood in the maternal circulation ranged from 92 to 370 ml.
Demographic features of the 24 affected neonates are shown in Table 1 Of the 24 neonates, 19 were delivered by emergent cesarean section due to non-reassuring fetal heart tracings, and all of these had an initial Hgb o8 g dl À 1 . Three (cases 3, 7 and 13) had sinusoidal fetal heart tracings charted. None of the 24 neonates was detected antenatally; none had cordocentesis or intrauterine transfusion. The pregnancy, before the day of delivery, was reported as uncomplicated in all but six cases; two of these had an amniocentesis, one (case 19) to relieve pleura fluid (nonimmune hydrops) and the other (case 22) to assess fetal lung maturity before delivery. One (case 12) had a car accident at 19 weeks of gestation; one (case 13) reported vaginal bleeding from 12 to 20 weeks of gestation; one (case 24) was taking one baby aspirin daily and was diagnosed with subchorionic hemorrhage in the first trimester.
The initial laboratory tests on the first day of life are shown in Table 2 . Nucleated red blood cell counts were above the reference range in 21 cases. 17 Thrombocytopenia was recognized on the first day in seven cases. All 24 cases had an initial pH 47.00. Weak positive correlations were identified between the initial Hgb and the first base excess (R 2 ¼ 0.089) and between initial Hgb and first pH (R 2 ¼ 0.051). Negative correlations were identified between initial Hgb and nucleated red blood cell count (R 2 ¼ 0.272), and between initial Hgb and reticulocyte count (R 2 ¼ 0.153). Clinical presentation and interventions during the first day are shown in Table 3 in association with the initial Hgb. Low Apgar scores were common among those with an initial Hgb o5 g dl received chest compressions for resuscitation after delivery. In addition, 14 cases received mechanical ventilation and 7 cases received vasopressors. A total of 21 neonates received red blood cell transfusions on the first day; 14 of these were emergent uncrossmatched type O ( À ) erythrocytes. All four neonates born at o32 weeks of gestation also received platelets and fresh frozen plasma on the first day. Of the 24 neonates, 5 were not admitted to the neonatal intensive care unit immediately after birth. These five neonates, all with Hgb X5.8 g dl À 1 , were initially cared for in a well-baby unit until 4 to 12 h after birth, when respiratory distress was observed and anemia was diagnosed.
Neonatal morbidities are shown in Table 4 . Of the two neonates with the lowest initial Hgb, one died on the first day and the other developed a severe IVH with posthemorrhagic hydrocephalus, resulting in ventriculoperitoneal shunting and poor neurodevelopmental outcome. Death, IVH, periventricular leukomalacia, bronchopulmonary dysplasia or hypoxic-ischemic encephalopathy occurred in 17 of the 24 neonates, including all of 8 born at p35 weeks of gestation.
DISCUSSION
Anemia at birth is an important problem, but one that is incompletely understood. The complexity of the condition is derived from the various etiologies, mechanisms, kinetics and genetics involved. 18 In an attempt to improve our understanding of anemia at birth, and thereby improve outcomes, we have engaged in a step-wise approach, including first defining the reference ranges for Hct/Hgb, red blood cell indices and nucleated red blood cell count according to gestational and postnatal age. 17, 19, 20 The present study was undertaken as another step; focusing on the subgroup of neonates with anemia at birth and evidence of fetomaternal hemorrhage.
Fetomaternal hemorrhage can require the rapid, intensive and coordinated efforts of Obstetrics, Pediatrics, Neonatology, the transfusion service and the clinical laboratory. 2 Fortunately, the condition is rare. However if, as our present data suggest, 1 case occurs in each 9000 live births, B450 to 500 liveborn neonates are affected in the United States each year. We recognize that our calculations underestimate the actual incidence. First, our catchment criteria for this study miss those with anemia but no Kleihauer-Betke testing, and those with anemia too mild to produce signs prompting neonatal intensive care unit admission, and those with a hemorrhage occurring only early in pregnancy. Second, fetomaternal hemorrhage can cause stillbirth and we made no attempt to study stillbirths. However, using Intermountain Healthcare and University of Utah data, Silver et al. 7 estimated that 3 to 14% of stillbirths follow fetomaternal hemorrhage.
Outcomes of liveborn neonates after fetomaternal hemorrhage include neonatal death and various neonatal morbidities. 2, 5 Perhaps 20 to 30% of affected neonates have one or more of these outcomes, with higher odds of a poor outcome if born prematurely or with Hgb o3 g dl À 1 . 2, 5 Means of improving the care of these patients, and increasing the odds of a good outcome, are surely needed.
Many important issues relevant to fetomaternal hemorrhage are unresolved. For instance, it is unclear how much fetal blood must be lost before the fetus is seriously endangered. Studies by Brace, 21 using fetal sheep, indicate that if the rate of blood loss is slow, a loss of up to 30% of the intravascular volume can be tolerated. However, with acute blood loss the chance for fetal damage is much higher. With hyperacute hemorrhage (occurring within minutes to an hour before birth), the Hgb and Hct of a neonate might be normal at birth. Only after the intravascular volume increases by ingressing fluid will the Hgb fall from dilution. As all 16 of our patients with Hgb o6 g dl À 1 were first measured within minutes to an hour after birth, and all were low, we assume that hyperacute hemorrhage was not present in these patients.
The lack of hydrops at birth in 23 of our 24 patients, despite a very low Hgb, may give some understanding of the timing of the hemorrhage. Hydrops from anemia takes a period of time to develop. Observational reports suggest that hydrops can develop Abbreviations: ALT, alanine transaminase; aPTT, activated partial thromboplastin; ARC, absolute reticulocyte count; AST, aspartate transaminase; Fib, fibrinogen; Hct, hematocrit; Hgb, hemoglobin; MCV, mean corpuscular volume; NRBC, nucleated red blood cell; PT, prothrombin time; Retic, reticulocyte count; WBC, white blood cell. Blank cells indicate that the test was not performed in the first 24 h.
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if the fetal Hgb falls below B6 g dl À 1 for several days (4 to 6 days). 22 Of our 24 cases, 16 had an initial Hgb o6 g dl À 1 but none of these were hydropic. Thus, perhaps the hemorrhages occurred within only a day or two before birth, not giving time for hydrops to develop. We speculate that the hemorrhages in our cases were neither hyperacute nor did they occur many days before birth, but generally occurred in a period intermediate between these two.
Another important unknown aspect is the relationship between hemorrhage volume and odds of brain injury. Rubod et al. 5 concluded that when fetal blood loss exceeds 20 ml kg À 1 , the neonate generally requires neonatal intensive care unit care, when it exceeds 40 ml kg À 1 , the chance of stillbirth or major morbidity is significant and at 480 ml kg À 1 , adverse outcomes are invariable In our study, 8 of 23 (35%) surviving infants had evidence of brain injury. In contrast, neurologic injury was found in only 0 to 4% of surviving infants in smaller series. 3, 5 We suspect than many neonates in previous reports were not as severely affected as most of the neonates in the present report. Accurate data on brain injury from fetomaternal hemorrhage are elusive because some fetuses might sustain brain damage from hemorrhage months before delivery, yet not be anemic at birth.
If adverse consequences of fetomaternal hemorrhage are to be avoided, it is important to diagnose this process and intervene as early as possible. However, we had no cases where an antenatal diagnosis was made. Obstetricians generally perform testing for fetomaternal hemorrhage in a limited number of situations; abdominal trauma, abruption, fetal hydrops and stillbirth. Gacoia 23 found no case where maternal trauma or abruption were antecedent to fetomaternal hemorrhage. In our series, only one case had trauma during pregnancy (a car accident), and two had vaginal bleeding. Neither of the vaginal bleeding case seemed to be from an acute abruption, and thus they would not likely have had a test for fetomaternal hemorrhage. Similarly, testing was not ordered on the woman after the car accident. The American College of Obstetrics and Gynecology does not recommend testing for fetomaternal hemorrhage in women undergoing trauma except in cases in which the dose of Rhogam must be calculated. 24 Decreased or absent fetal movement was reported by mothers in 54% of our cases and in 27% of those reviewed by Gacoia. 23 In both series, this was by far the most common presenting sign or symptom. These reports raise the question as to whether maternal perception of fetal movement could be a useful screening method for severe fetomaternal hemorrhage. However, in obstetric practice it is quite common for patients to report decreased movement, and it is not clear whether this should always prompt a consideration of fetomaternal hemorrhage. When decreased fetal movement is reported, a typical response is to perform a nonstress test or biophysical profile. In our study, 19 of the 24 had a 'non-reassuring' fetal heart rate pattern prompting an emergent cesarean section. Thus, perhaps a normal nonstress test or biophysical profile might indeed be reassuring that a significant hemorrhage has not occurred. Our database did not allow us to precisely define the type of 'non-reassuring' fetal heart rate pattern present. The classic pattern with severe fetal anemia resembles a sine wave (hence the term 'sinusoidal'). However, this pattern was seen in only 16% of the patients reviewed by Gacoia 23 and in only 3 (12.5%) of ours. It is unclear whether flow cytometry should be performed on all women reporting absent fetal movement. 25, 26 Laboratory confirmation of a hemorrhage could help prepare the pediatric providers and the transfusion service. However, on a practical level, many hospital laboratories do not have a rapid flow cytometric test for this purpose, and sending the specimen to a reference laboratory would require a delay. Moreover, the majority of women with a severe fetomaternal hemorrhage are delivered by emergent cesarean for 'non-reassuring' fetal heart rate patterns. Thus, in many cases there would not be time to perform flow cytometry and receive the result before the delivery. However, laboratory confirmation within a few hours after birth could be of value; providing clear evidence of the cause of the hypovolemia and estimating the volume of fetal blood lost.
We recognize weaknesses in our study, primarily the pitfalls prevalent in all retrospective analyses, including incomplete data, errors in initial recording and unintended introduction of bias based on the data elements selected for review. Strengths include the relatively large number of cases included, all within one health system, and an electronic database of integrated maternal and neonatal information. Surely, much discovery is needed before the best ways to diagnose and treat this condition are defined. Table 5 is our attempt to summarize needed areas of improvement, based on our study of the present 24 cases. We speculate that better outcomes could occur with heightened antenatal suspicion, more rapid diagnosis and better preparation of first responders including labor and delivery and pediatric nurses, pediatricians and neonatologists and blood banks.
